Pharmaceutical company in India

Add to Favorites list
Add to Compare list
id - 239
icon
India
Pharmaceuticals
icon
536
  • Pharmaceutical company in India
  • Pharmaceutical company in India
    Pharmaceutical company in India
  • Revenue (year) 306,500,000 $
    12,815,152,256 ₺
    Profit (year) 87,500,000 $
    3,658,485,555 ₺
    Payback (mon.)
    Description

    Multinational pharmaceutical company headquartered in India is for sale. It is one of the leading generic pharmaceutical companies in Asia, it operates in more than 30 countries and has a diverse portfolio of products ranging from prescription drugs to over-the-counter medications and active pharmaceutical ingredients.

    The company is known for its strong research and development capabilities and has a reputation for manufacturing high-quality and affordable medicines. The company is committed to improving access to healthcare globally and strives to make a positive impact on people’s lives through its innovative products and sustainable practices.

    Currently the company do mostly private label, do not commercialize its own brand, but manufacture most of the common pharmaceutical forms (syrups, capsules, tablets, powders, lotions, solutions etc.).

    Keypoints:

    • Focused on manufacturing and marketing generic drugs, active pharmaceutical ingredients (APIs), and custom pharmaceutical services.
    • The company has a diverse portfolio of products spanning various therapeutic categories, including cardiovascular, neurology, gastrointestinal, dermatology, and oncology.
    • Global presence and operates in more than 30 countries worldwide.
    • Strong focus on research and development, investing a significant portion of its revenues in R&D activities.
    • Dedicated team of scientists and researchers who work on developing new drug formulations and improving existing ones.
    • Robust pipeline of new products, with several filings and approvals in various countries.
    • Known for its emphasis on quality and compliance with international regulatory standards.
    • Several manufacturing facilities in India and abroad, which adhere to good manufacturing practices (GMP) guidelines.
    • Strong track record of successfully launching and marketing generic versions of blockbuster drugs globally.
    • Established partnerships and collaborations with leading pharmaceutical companies to access new molecules and markets.

    All the property, equipment and real estate are included to the price.

    To obtain the details, the potential buyer must sign the NDA and send the POF.

    The information in the catalog is not an exact offer. The parameters of the deal are specified during negotiations with the seller.

    To perform this action, you must log in or register on the site.
    Start negotiation
    Similar adverts
    icon
    Kazakhstan
    Pharmaceutical production in western Kazakhstan Pharmaceutical production in western Kazakhstan
    Revenue (year)
    No data
    Profit (year)
    No data
    Payback (mon.)
    Price
    3,000,000,000 ₸
    233,218,372 ₺
    icon
    Jordan
    Pharmaceutical manufacturing company in Jordan Pharmaceutical manufacturing company in Jordan
    Revenue (year)
    37,000,000 $
    1,547,016,749 ₺
    Profit (year)
    6,300,000 $
    263,410,960 ₺
    Payback (mon.)
    Price
    45,000,000 $
    1,881,506,857 ₺
    icon
    Colombia
    Pharmaceutical company in Colombia Pharmaceutical company in Colombia
    Revenue (year)
    2,000,000 $
    83,622,527 ₺
    Profit (year)
    450,000 $
    18,815,069 ₺
    Payback (mon.)
    Price
    11,500,000 $
    480,829,530 ₺
    Previously viewed
    icon
    Russia
    Cheese factory in the Central Federal District, Russia Cheese factory in the Central Federal District, Russia
    Price
    500,000,000 ₽
    258,147,124 ₺
    icon
    Tanzania
    Oil depot in Dar es Salaam, Tanzania Oil depot in Dar es Salaam, Tanzania
    Price
    95,000,000 $
    3,972,070,031 ₺
    icon
    Zambia
    Oil depot in Zambia Oil depot in Zambia
    Price
    7,000,000 $
    292,678,845 ₺
    Currency rates calculator
    Contact REAB
    Contact REAB
    Messengers for this number